| Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis CJL Murray, KS Ikuta, F Sharara, L Swetschinski, GR Aguilar, A Gray, ... The lancet 399 (10325), 629-655, 2022 | 11133 | 2022 |
| The Alexander Project 1998–2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents MR Jacobs, D Felmingham, PC Appelbaum, RN Grüneberg Journal of Antimicrobial Chemotherapy 52 (2), 229-246, 2003 | 765 | 2003 |
| Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients SD Ahuja, D Ashkin, M Avendano, R Banerjee, M Bauer, JN Bayona, ... PLOS Medicine 9 (8), e1001300, 2012 | 748 | 2012 |
| International Surveillance of Bloodstream Infections Due toCandida Species: Frequency of Occurrence and In Vitro Susceptibilities to Fluconazole, Ravuconazole … MA Pfaller, DJ Diekema, RN Jones, HS Sader, AC Fluit, RJ Hollis, ... Journal of Clinical Microbiology 39 (9), 3254-3259, 2001 | 624 | 2001 |
| Global Phylogeny of Mycobacterium tuberculosis Based on Single Nucleotide Polymorphism (SNP) Analysis: Insights into Tuberculosis Evolution, Phylogenetic … I Filliol, AS Motiwala, M Cavatore, W Qi, MH Hazbón, ... Journal of bacteriology 188 (2), 759-772, 2006 | 564 | 2006 |
| Population Genetics Study of Isoniazid Resistance Mutations and Evolution of Multidrug-Resistant Mycobacterium tuberculosis MH Hazbón, M Brimacombe, M Bobadilla del Valle, M Cavatore, ... Antimicrobial agents and chemotherapy 50 (8), 2640-2649, 2006 | 563 | 2006 |
| Ready for a world without antibiotics? The pensières antibiotic resistance call to action J Carlet, V Jarlier, S Harbarth, A Voss, H Goossens, D Pittet, ... Antimicrobial resistance and infection control 1, 1-13, 2012 | 547* | 2012 |
| Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida MA Pfaller, DJ Diekema, ... Clinical Microbiology and Infection 10, 11-23, 2004 | 545 | 2004 |
| The Alexander Project 1996–1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections D Felmingham, RN Grüneberg Journal of Antimicrobial Chemotherapy 45 (2), 191-203, 2000 | 540 | 2000 |
| Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes D Falzon, N Gandhi, GB Migliori, G Sotgiu, HS Cox, TH Holtz, ... European Respiratory Journal 42 (1), 156-168, 2013 | 509 | 2013 |
| Epidemiology of candidemia in Latin America: a laboratory-based survey M Nucci, F Queiroz-Telles, T Alvarado-Matute, IN Tiraboschi, J Cortes, ... PloS one 8 (3), e59373, 2013 | 503 | 2013 |
| Bloodstream Infections Due to Candida Species: SENTRY Antimicrobial Surveillance Program in North America and Latin America, 1997-1998 MA Pfaller, RN Jones, GV Doern, HS Sader, SA Messer, A Houston, ... Antimicrobial Agents and Chemotherapy 44 (3), 747-751, 2000 | 492 | 2000 |
| Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or … Y Carmeli, J Armstrong, PJ Laud, P Newell, G Stone, A Wardman, ... Lancet Infectious Diseases 16 (6), 661-673, 2016 | 463 | 2016 |
| Trends in Antifungal Susceptibility of Candida spp. Isolated from Pediatric and Adult Patients with Bloodstream Infections: SENTRY Antimicrobial Surveillance … MA Pfaller, DJ Diekema, RN Jones, SA Messer, RJ Hollis Journal of clinical microbiology 40 (3), 852-856, 2002 | 450 | 2002 |
| Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes ME Jiménez-Corona, LP Cruz-Hervert, L García-García, L Ferreyra-Reyes, ... Thorax 68 (3), 214-220, 2013 | 426 | 2013 |
| Tuberculosis and diabetes in southern Mexico A Ponce-De-Leon, ML Garcia-Garcia, MC Garcia-Sancho, ... Diabetes care 27 (7), 1584-1590, 2004 | 411* | 2004 |
| Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis GB Migliori, G Sotgiu, NR Gandhi, D Falzon, K DeRiemer, R Centis, ... European Respiratory Journal 42 (1), 169-179, 2013 | 325 | 2013 |
| Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 M Naghavi, SE Vollset, KS Ikuta, LR Swetschinski, AP Gray, EE Wool, ... The Lancet 404 (10459), 1199-1226, 2024 | 302 | 2024 |
| Urinary tract infection trends in Latin American hospitals: report from the SENTRY antimicrobial surveillance program (1997–2000) AC Gales, HS Sader, RN Jones, SENTRY Participants Group Diagnostic microbiology and infectious disease 44 (3), 289-299, 2002 | 272 | 2002 |
| Investigación sobre epidemiología convencional y molecular de tuberculosis en Orizaba, Veracruz, 1995-2008 ME Jiménez-Corona, L García-García, AP León, M Bobadilla-del Valle, ... salud pública de méxico 51, s470-s478, 2009 | 266* | 2009 |
Miriam Bobadilla del ValleLaboratorio de Microbiología Clínica, Instituto Nacional de Ciencias Médicas y Nutrición Salvador ZubiránVerified email at incmnsz.mx
